Advances in the Management of Pulmonary Arterial Hypertension [[electronic resource]] |
Autore | Yuan Jason X-J |
Edizione | [1st ed.] |
Pubbl/distr/stampa | London, : Future Medicine Ltd, 2013 |
Descrizione fisica | 1 online resource (129 p.) |
Disciplina | 616.1/32 |
Altri autori (Persone) | SmithKimberly A |
Soggetto topico |
Pulmonary hypertension -- Treatment
Pulmonary hypertension |
Soggetto genere / forma | Electronic books. |
ISBN | 1-78084-309-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension
9. Right ventricular failureIndex |
Record Nr. | UNINA-9910465455503321 |
Yuan Jason X-J | ||
London, : Future Medicine Ltd, 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Advances in the management of pulmonary arterial hypertension / / editors, Kimberly A. Smith, Dustin R. Fraidenburg, Jason X.-J. Yuan |
Edizione | [1st ed.] |
Pubbl/distr/stampa | London, England : , : Future Medicine Ltd., , [2013] |
Descrizione fisica | 1 online resource (129 p.) |
Disciplina | 616.24 |
Soggetto topico |
Pulmonary hypertension
Pulmonary hypertension - Treatment |
ISBN | 1-78084-309-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension
9. Right ventricular failureIndex |
Record Nr. | UNINA-9910792287203321 |
London, England : , : Future Medicine Ltd., , [2013] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Advances in the management of pulmonary arterial hypertension / / editors, Kimberly A. Smith, Dustin R. Fraidenburg, Jason X.-J. Yuan |
Edizione | [1st ed.] |
Pubbl/distr/stampa | London, England : , : Future Medicine Ltd., , [2013] |
Descrizione fisica | 1 online resource (129 p.) |
Disciplina | 616.24 |
Soggetto topico |
Pulmonary hypertension
Pulmonary hypertension - Treatment |
ISBN | 1-78084-309-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension
9. Right ventricular failureIndex |
Record Nr. | UNINA-9910814257003321 |
London, England : , : Future Medicine Ltd., , [2013] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Balloon pulmonary angioplasty in patients with CTEPH / / Francesco Saia, Nazzareno Galiè and Hiromi Matsubara, editors |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (131 pages) |
Disciplina | 616.24 |
Soggetto topico |
Pulmonary hypertension
Transluminal angioplasty Pulmonary hypertension - Treatment |
ISBN | 3-030-95997-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910735401403321 |
Cham, Switzerland : , : Springer, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Current medical literature Pulmonary hypertension |
Pubbl/distr/stampa | London : , : Remedica Medical Education and Publishing, , 2010- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Pulmonary hypertension
Hypertension pulmonaire - Recherche Hypertension pulmonaire - Traitement |
Soggetto genere / forma | Periodicals. |
ISSN | 2041-1707 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996336161603316 |
London : , : Remedica Medical Education and Publishing, , 2010- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Interventional Pulmonology and Pulmonary Hypertension / / edited by Theodoros Aslanidis |
Pubbl/distr/stampa | London, United Kingdom : , : IntechOpen, , 2020 |
Descrizione fisica | 1 online resource (114 pages) |
Disciplina | 616.24 |
Soggetto topico |
Lungs - Diseases
Pulmonary hypertension |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Interventional Pulmonology and Pulmonary Hypertension |
Record Nr. | UNINA-9910688485203321 |
London, United Kingdom : , : IntechOpen, , 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pulmonary arterial hypertension [[electronic resource] ] : focusing on a future : enhancing and extending life / / edited by J. Antel, M.B. Hesselink and R.T. Schermuly |
Pubbl/distr/stampa | Amsterdam, : IOS Press, 2010 |
Descrizione fisica | 1 online resource (116 p.) |
Disciplina |
616.1
616.1/32 |
Altri autori (Persone) |
AntelJ (Jochen)
HesselinkM. B SchermulyR. T |
Collana | Solvay Pharmaceuticals Conferences |
Soggetto topico | Pulmonary hypertension |
Soggetto genere / forma | Electronic books. |
ISBN |
6612880457
1-282-88045-4 9786612880452 1-60750-609-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Preface; List of Contributors; Contents; Conference Preface; Surgical Treatment of Pulmonary Arterial Hypertension; Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Need for a More Focused Approach; Established and New Therapies for Hypoxia and Non-Hypoxia-Related Pulmonary Hypertension; Novel Anti-Proliferative Therapies in Pulmonary Hypertension; What Animal Models Tell Us About Treatments for Pulmonary Hypertension; Therapeutic Potential for Dual Inhibition of Endothelin Converting Enzyme and Neutral Endopeptidase in Pulmonary Arterial Hypertension
Pulmonary Vascular Disease in the Newborn - From Pathophysiology to Therapeutic StrategiesFrom Concept to Therapy - Alternative Route of Drug Application: Inhalation; Author Index |
Record Nr. | UNINA-9910458776203321 |
Amsterdam, : IOS Press, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pulmonary arterial hypertension [[electronic resource] ] : focusing on a future : enhancing and extending life / / edited by J. Antel, M.B. Hesselink and R.T. Schermuly |
Pubbl/distr/stampa | Amsterdam, : IOS Press, 2010 |
Descrizione fisica | 1 online resource (116 p.) |
Disciplina |
616.1
616.1/32 |
Altri autori (Persone) |
AntelJ (Jochen)
HesselinkM. B SchermulyR. T |
Collana | Solvay Pharmaceuticals Conferences |
Soggetto topico | Pulmonary hypertension |
ISBN |
6612880457
1-282-88045-4 9786612880452 1-60750-609-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Preface; List of Contributors; Contents; Conference Preface; Surgical Treatment of Pulmonary Arterial Hypertension; Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Need for a More Focused Approach; Established and New Therapies for Hypoxia and Non-Hypoxia-Related Pulmonary Hypertension; Novel Anti-Proliferative Therapies in Pulmonary Hypertension; What Animal Models Tell Us About Treatments for Pulmonary Hypertension; Therapeutic Potential for Dual Inhibition of Endothelin Converting Enzyme and Neutral Endopeptidase in Pulmonary Arterial Hypertension
Pulmonary Vascular Disease in the Newborn - From Pathophysiology to Therapeutic StrategiesFrom Concept to Therapy - Alternative Route of Drug Application: Inhalation; Author Index |
Record Nr. | UNINA-9910785115703321 |
Amsterdam, : IOS Press, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pulmonary arterial hypertension [[electronic resource] ] : focusing on a future : enhancing and extending life / / edited by J. Antel, M.B. Hesselink and R.T. Schermuly |
Pubbl/distr/stampa | Amsterdam, : IOS Press, 2010 |
Descrizione fisica | 1 online resource (116 p.) |
Disciplina |
616.1
616.1/32 |
Altri autori (Persone) |
AntelJ (Jochen)
HesselinkM. B SchermulyR. T |
Collana | Solvay Pharmaceuticals Conferences |
Soggetto topico | Pulmonary hypertension |
ISBN |
6612880457
1-282-88045-4 9786612880452 1-60750-609-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Title page; Preface; List of Contributors; Contents; Conference Preface; Surgical Treatment of Pulmonary Arterial Hypertension; Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Need for a More Focused Approach; Established and New Therapies for Hypoxia and Non-Hypoxia-Related Pulmonary Hypertension; Novel Anti-Proliferative Therapies in Pulmonary Hypertension; What Animal Models Tell Us About Treatments for Pulmonary Hypertension; Therapeutic Potential for Dual Inhibition of Endothelin Converting Enzyme and Neutral Endopeptidase in Pulmonary Arterial Hypertension
Pulmonary Vascular Disease in the Newborn - From Pathophysiology to Therapeutic StrategiesFrom Concept to Therapy - Alternative Route of Drug Application: Inhalation; Author Index |
Record Nr. | UNINA-9910812663103321 |
Amsterdam, : IOS Press, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pulmonary arterial hypertension [[electronic resource] ] : diagnosis and evidence-based treatment / / edited by Robyn J. Barst |
Pubbl/distr/stampa | Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 |
Descrizione fisica | 1 online resource (280 p.) |
Disciplina |
616.132
616.2/4 |
Altri autori (Persone) | BarstRobyn J <1950-> (Robyn Joan) |
Soggetto topico |
Pulmonary hypertension
Evidence-based medicine |
ISBN |
1-281-84133-1
9786611841331 0-470-99739-7 0-470-99738-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Pulmonary Arterial Hypertension; Contents; Preface; Contributors; 1 Introduction; 2 Diagnosis and assessment of pulmonary arterial hypertension; 2.1 Hemodynamics of pulmonary hypertension; 2.2 Venice classification; 2.3 Overview of the diagnostic process (algorithm); 2.4 Screening (identifying a pre-existing risk); 2.5 Detection (discovering pulmonary hypertension); 2.6 Definition (diagnosing the clinical context); 2.7 Prediction (estimating prognosis); 2.8 Principles of follow-up (evaluating and responding to outcome); 2.9 Specific tests in the evaluation of pulmonary hypertension
3 Conventional therapy in pulmonary arterial hypertension3.1 Calcium channel antagonists; 3.2 Diuretics; 3.3 Warfarin; 3.4 Supplemental oxygen; 3.5 Inotropic therapy; 3.6 General measures; 3.7 Conclusions; 4 Prostanoid treatment for pulmonary arterial hypertension; 4.1 Epoprostenol; 4.2 Treprostinil; 4.3 Iloprost; 4.4 Beraprost; 4.5 Treatment selection; 4.6 Conclusions; 5 Endothelin receptor antagonists in pulmonary arterial hypertension; 5.1 Bosentan; 5.2 Sitaxsentan; 5.3 Ambrisentan; 5.4 Safety and tolerability with endothelin receptor antagonists; 5.5 Conclusions 6 Phosphodiesterase-5 inhibitors in pulmonary arterial hypertension6.1 The origins of phosphodiesterase-5 inhibitor development; 6.2 Pulmonary hypertension as a new indication for phosphodiesterase-5 inhibitor treatment; 6.3 Role of phosphodiesterase-5 in the pulmonary vasculature; 6.4 Clinical experience with sildenafil for the treatment of chronic pulmonary hypertension; 6.5 Pivotal trial and approval of sildenafil for the treatment of pulmonary arterial hypertension (SUPER-1 study); 6.6 Other phosphodiesterase-5 inhibitors; 6.7 Combination therapy 6.8 Potential new indications for phosphodiesterase-5 inhibitors outside pulmonary arterial hypertension6.9 Conclusions; 7 Combination therapy for pulmonary arterial hypertension; 7.1 Background; 7.2 Combination therapy to date; 7.3 Conclusions; 8 Interventional and surgical modalities of treatment for pulmonary arterial hypertension; 8.1 Introduction; 8.2 Atrial septostomy; 8.3 Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension; 8.4 Lung transplantation for pulmonary hypertension; 8.5 Conclusions 9 End points and clinical trial design in pulmonary arterial hypertension: Clinical and regulatory perspectives9.1 Introduction; 9.2 Trial design; 9.3 End points in trials of therapy for pulmonary arterial hypertension; 9.4 Conclusions; 10 Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension; 10.1 Introduction; 10.2 Randomized controlled studies; 10.3 Long-term continuation studies; 10.4 Combination studies; 10.5 Evidence-based treatment algorithm; 10.6 Conclusions 11 Diagnosis and assessment of non-pulmonary arterial hypertension masquerading as idiopathic pulmonary arterial hypertension: Diastolic heart failure - evaluation and interactions |
Record Nr. | UNINA-9910144119603321 |
Chichester, England ; ; Hoboken, NJ, : John Wiley & Sons, c2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|